The article examines the ethical debate surrounding polygenic embryo screening, a genetic testing method that assesses embryos for multiple conditions like cancer, obesity, and autism. Critics voice concerns over the accuracy of risk scores and the possible societal impact of selecting embryos based on these assessments. The implications of such technology extend beyond individual choice, touching on cultural perceptions of disability, diversity, and the worth of different lives. Experts Vardit Ravitsky and Katie Hasson contribute insights on the dangers inherent in this technology, advocating for an ethical framework as its use expands.
"Polygenic embryo screening raises critical ethical questions about diversity and the inherent value of every life, putting societal ideas about what it means to live at stake."
"The risk scores generated by genetic testing lack transparency, leaving researchers and potential parents questioning the reliability of these assessments for complex conditions."
Collection
[
|
...
]